UNII Z8IX2SC1OH

PROPYLPARABEN

Unique Ingredient Identifier Z8IX2SC1OH is listed as a ingredient substance
UniiZ8IX2SC1OH
Preferred Substance NamePROPYLPARABEN
Rn94-13-3
Ec202-307-7
NcitC76730
Rxcui34706
Pubchem7175
Molecular FormulaC10H12O3
InchikeyQELSKZZBTMNZEB-UHFFFAOYSA-N
SmilesCCCOC(=O)C1=CC=C(O)C=C1
Unii TypeINGREDIENT SUBSTANCE
RN94-13-3
EC202-307-7
NCITC76730
RXCUI34706
PUBCHEM7175
MFC10H12O3
INCHI KEYQELSKZZBTMNZEB-UHFFFAOYSA-N
SMILESCCCOC(=O)C1=CC=C(O)C=C1

Alternate Names

Dosage Forms

UNII Z8IX2SC1OH PROPYLPARABEN is commonly included in medications in the following forms.

RouteDosage FormPotency
AN,INFILTRATIONINJECTION0.01 %
AURICULAR (OTIC)SUSPENSION0.001 %
BUCCALFILM0.22 MG
BUCCALFILM, SOLUBLE0.18 MG
IM - IVINJECTABLE0.015 %
IM - IVINJECTION0.2 %
IM - IVPOWDER, FOR INJECTION SOLUTION0.04 %
IM - IVSOLUTION0.016 %
IM - IV - SCINJECTION20 %
IM - SCINJECTION0.02 %
INTRA-ARTERIALINJECTION NA
INTRA-ARTICULARINJECTION0.16 %
INTRABURSALINJECTION0.02 %
INTRALESIONALINJECTION0.02 %
INTRAMUSCULARINJECTABLE0.02 %W/V
INTRAMUSCULARINJECTION0.16 %
INTRAMUSCULARINJECTION, SOLUTION0.2 MG/1ML
INTRAMUSCULARINJECTION, SUSPENSION0.015 %
INTRAMUSCULARSOLUTION, INJECTION NA
INTRAMUSCULARSUSPENSION0.02 %
INTRAMUSCULARSUSPENSION, INJECTION0.15 MG/1ML
INTRAMUSCULARSUSPENSION, INJECTION0.015 %W/V
INTRASYNOVIALINJECTION NA
INTRATUMORINJECTION0.02 %
INTRAVASCULARINJECTION0.03 %
INTRAVENOUSINJECTABLE0.08 %
INTRAVENOUSINJECTION0.1 %
INTRAVENOUSINJECTION, SOLUTION0.2 MG/1ML
INTRAVENOUSLIQUID, WATER, STERILE, FOR INJECTION0.02 %
INTRAVENOUSPOWDER, FOR INJECTION SOLUTION0.08 %
INTRAVENOUSSOLUTION, INJECTION0.02 %
INTRAVENOUS INFUSIONINJECTION0.2 MG/1ML
IV - SCINJECTION0.15 MG/1ML
IV - SCINJECTION0.02 %
IV(INFUSION)INJECTION0.056 %
IV(INFUSION)POWDER, FOR INJECTION SOLUTION0.04 %
NASALSOLUTION0.017 %
NASALSOLUTION, SPRAY0.02 %
NASALSPRAY, METERED0.3 %
NERVE BLOCKINJECTION0.035 %
OPHTHALMICOINTMENT0.01 %
OPHTHALMICSOLUTION0.015 %
OPHTHALMICSOLUTION, DROPS0.011 %
OPHTHALMICSUSPENSION0.01 %
OPHTHALMICSUSPENSION, DROPS0.01 %
ORALCAPSULE0.21 MG
ORALCAPSULE (IMMED./COMP. RELEASE), SOFT GELATIN, PERL0.081 MG
ORALCAPSULE, COATED, SOFT GELATIN0.053 MG
ORALCAPSULE, HARD GELATIN NA
ORALCAPSULE, SOFT GELATIN0.12 MG
ORALCAPSULE, SUSTAINED ACTION0.22 MG
ORALCONCENTRATE2.5 MG/5ML
ORALDROPS NA
ORALEMULSION NA
ORALLIQUID0.2 MG/1ML
ORALPOWDER0.04 %
ORALPOWDER, FOR ORAL SOLUTION0.15 MG
ORALPOWDER, FOR ORAL SUSPENSION0.08 %W/W
ORALPOWDER, FOR SOLUTION0.16 MG/1ML
ORALPOWDER, FOR SUSPENSION4 MG/5ML
ORALSOLUTION100 MG
ORALSOLUTION3 mg/15 mL
ORALSOLUTION1 MG/5ML
ORALSOLUTION0.1 MG/1ML
ORALSOLUTION0.017 %W/W
ORALSOLUTION, CONCENTRATE0.2 MG/1ML
ORALSOLUTION, ELIXIR3 MG/15ML
ORALSOLUTION, LIQUID0.2 MG/1ML
ORALSOLUTION, SYRUP1 MG/1ML
ORALSUSPENSION200 MG/5ML
ORALSUSPENSION1.95 MG/15 ML
ORALSUSPENSION0.32 mg/1mL
ORALSUSPENSION, EXTENDED RELEASE20 %
ORALSUSPENSION, LIQUID3 MG/5ML
ORALSUSPENSION, SUSTAINED ACTION1.5 MG/5ML
ORALSYRUP200 MG/5ML
ORALTABLET0.2 MG
ORALTABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE0.14 MG
ORALTABLET, COATED0.002 MG
ORALTABLET, FILM COATED0.04 MG
ORALTABLET, SUSTAINED ACTION0.12 MG
PARENTERALINJECTION0.02 %
RECTALAEROSOL, METERED0.009 %
RECTALLIQUID0.015 %
RECTALSOLUTION0.015 %
RECTALSUSPENSION0.034 %
SOFT TISSUEINJECTION0.02 %
SUBCUTANEOUSINJECTION0.03 %
SUBCUTANEOUSSUSPENSION, INJECTION0.023 %
TOPICALCREAM0.4 %W/W
TOPICALCREAM, AUGMENTED0.1 %W/W
TOPICALCREAM, EMULSION, SUSTAINED RELEASE0.1 %W/W
TOPICALEMULSION0.06 %W/W
TOPICALEMULSION, AEROSOL FOAM0.011 %W/W
TOPICALEMULSION, CREAM5.25 %W/W
TOPICALEMULSION, LOTION0.06 %W/W
TOPICALGEL0.05 %W/W
TOPICALJELLY0.03 %W/V
TOPICALLOTION0.2 %W/W
TOPICALOINTMENT0.2 %W/W
TOPICALPATCH NA
TOPICALPATCH, CONTROLLED RELEASE NA
TOPICALSHAMPOO0.03 %W/W
TOPICALSOLUTION0.033 %W/W
TOPICALSPRAY0.8 %W/W
URETERALSOLUTION NA
URETHRALINJECTION0.02 %
URETHRALJELLY0.03 %
VAGINALCREAM, EMULSION, SUSTAINED RELEASE0.05 %
VAGINALEMULSION, CREAM0.1 %
VAGINALGEL0.02 %
VAGINALSUPPOSITORY NA

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.